title: European studies of interleukin-2 in metastatic renal cell carcinoma.
authors.affiliation: Division of Hematology/Oncology, Medizinische Hochschule Hannover, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Atzpodien
authors.forename: H
authors.initials: H
authors.lastname: Kirchner
authors.forename: E L
authors.initials: EL
authors.lastname: Hänninen
authors.forename: A
authors.initials: A
authors.lastname: Körfer
authors.forename: M
authors.initials: M
authors.lastname: Fenner
authors.forename: T
authors.initials: T
authors.lastname: Menzel
authors.forename: M
authors.initials: M
authors.lastname: Deckert
authors.forename: A
authors.initials: A
authors.lastname: Franzke
authors.forename: U
authors.initials: U
authors.lastname: Jonas
authors.forename: H
authors.initials: H
authors.lastname: Poliwoda
mesh_terms: D000328:Adult; D000368:Aged; D000553:Ambulatory Care; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000556:secondary / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D007370:Interferon Type I / Q000008:administration & dosage / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D007370:Interferon Type I; D007376:Interleukin-2; D011994:Recombinant Proteins; C082598:aldesleukin; D005472:Fluorouracil